Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:53:20.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T16:54:44.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of publications related to a clinical study involving pembrolizumab and ibrutinib. Notably, previous references to certain location details and specific drug classifications have been removed.
    Difference
    6%
    Check dated 2025-08-31T12:09:38.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing older dates and adding new ones for August 2025. Additionally, it has clarified that the product is not manufactured in and exported from the U.S.
    Difference
    0.8%
    Check dated 2025-08-24T08:01:20.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:25:12.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:22:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.